Mao Nakayama
- Ophthalmology top 5%
- Glaucoma and retinal disorders 5
- Retinal Diseases and Treatments 3
-
- Retinal Development and Disorders 4
-
- Colorectal Cancer Surgical Treatments 4
- Colorectal Cancer Treatments and Studies 4
-
- Gastric Cancer Management and Outcomes 4
-
- Neuroendocrine Tumor Research Advances 3
- Multiple and Secondary Primary Cancers 3
- Co-authors
- Takeshi IwataDaisuke IejimaMakoto AiharaMakoto AraieYi‐Ning ChenYuriko MinegishiKazuhide KawaseKaori Tomita‐Yokotani
- Cited by
- OphthalmologyNeurologyPharmacology
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)PLoS ONE (1 paper)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Mao Nakayama
34 papers receiving 410 citations
Peers
Comparison fields: 5 of 74
- Ophthalmology 177
- Neurology 56
- Pharmacology 33
- Molecular Biology 215
- Neurology 44
Countries citing papers authored by Mao Nakayama
This map shows the geographic impact of Mao Nakayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mao Nakayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mao Nakayama more than expected).
Fields of papers citing papers by Mao Nakayama
This network shows the impact of papers produced by Mao Nakayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mao Nakayama. The network helps show where Mao Nakayama may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mao Nakayama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 21 | |
| 4 | 2021 | 11 | |
| 5 | 2018 | 8 | |
| 6 | 2016 | 88 | |
| 7 | Human HTRA1 expression is enhanced by indel mutation in the HTRA1 regulatory element region. | 2015 | 1 |
| 8 | Incidence and risk factors for incisional hernia after open surgery for colorectal cancer. | 2014 | 11 |
| 9 | 2014 | 0 | |
| 10 | Hyperbaric pressure and increased susceptibility to glutamate toxicity in retinal ganglion cells in vitro. | 2014 | 16 |
| 11 | [Successful resection of recurrent lesions in a patient with ovarian torsion diagnosed with rectal cancer]. | 2014 | 1 |
| 12 | Liquid tissue adhesive, subcuticular suture and subcutaneous closed suction drain for wound closure as measures for wound infection in a colorectal cancer surgery with stoma creation. | 2014 | 1 |
| 13 | Practical use of capecitabine plus oxaliplatin (CAPEOX) with bevacizumab for patients with metastatic colorectal cancer that cannot expect conversion therapy. | 2014 | 3 |
| 14 | 2013 | 0 | |
| 15 | 2013 | 0 | |
| 16 | 2011 | 0 | |
| 17 | 2011 | 1 | |
| 18 | A case of synergistic divergence with duane's syndrome like bulbar retraction | 1988 | 1 |
| 19 | 1986 | 1 | |
| 20 | 1979 | 58 |
About Mao Nakayama
Mao Nakayama is a scholar working on Ophthalmology, Oncology and Hepatology, having authored 41 papers that have together received 422 indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (5 papers), Colorectal Cancer Surgical Treatments (4 papers), Gastric Cancer Management and Outcomes (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Retinal Development and Disorders (4 papers), Retinal Diseases and Treatments (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Multiple and Secondary Primary Cancers (3 papers). The work is most often cited by research in Ophthalmology (177 citations), Neurology (56 citations) and Pharmacology (33 citations). Mao Nakayama has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Takeshi Iwata, Daisuke Iejima, Makoto Aihara, Makoto Araie, Yi‐Ning Chen, Yuriko Minegishi, Kazuhide Kawase, Kaori Tomita‐Yokotani, Tsukasa Iwashina and Asako Goto. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.